Mamoru Yanagimachi

605 total citations
12 papers, 499 citations indexed

About

Mamoru Yanagimachi is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Mamoru Yanagimachi has authored 12 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Mamoru Yanagimachi's work include Computational Drug Discovery Methods (3 papers), Lipoproteins and Cardiovascular Health (3 papers) and Plant biochemistry and biosynthesis (3 papers). Mamoru Yanagimachi is often cited by papers focused on Computational Drug Discovery Methods (3 papers), Lipoproteins and Cardiovascular Health (3 papers) and Plant biochemistry and biosynthesis (3 papers). Mamoru Yanagimachi collaborates with scholars based in Japan and United States. Mamoru Yanagimachi's co-authors include Pavan Kumar, Zoltán Dezső, Judy Oestreicher, Michael Byrne, Crystal MacKenzie, Ken Aoshima, Sergei Agoulnik, Yoshiya Oda, François P. Bernier and Masashi Ito and has published in prestigious journals such as PLoS ONE, Circulation Research and Cancer Research.

In The Last Decade

Mamoru Yanagimachi

12 papers receiving 491 citations

Peers

Countries citing papers authored by Mamoru Yanagimachi

Since Specialization

Citations

This map shows the geographic impact of Mamoru Yanagimachi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mamoru Yanagimachi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mamoru Yanagimachi more than expected).

Fields of papers citing papers by Mamoru Yanagimachi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mamoru Yanagimachi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mamoru Yanagimachi. The network helps show where Mamoru Yanagimachi may publish in the future.

Co-authorship network of co-authors of Mamoru Yanagimachi

This figure shows the co-authorship network connecting the top 25 collaborators of Mamoru Yanagimachi. A scholar is included among the top collaborators of Mamoru Yanagimachi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mamoru Yanagimachi. Mamoru Yanagimachi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Olfactory function evaluation in a 1102 community-dwelling 20-90-year old Japanese population in relation with age, sex and mental decline 2017 ·Mamoru Yanagimachi, Ippei Takahashi, François P. Bernier, Kentaro Takahashi, (unknown), (unknown), Akira Sasaki, (unknown), Atsushi Matsubara, Shigeyuki Nakaji	4
2	Circulating miRNA Biomarkers for Alzheimer's Disease 2013 ·PLoS ONE ·Pavan Kumar, Zoltán Dezső, Crystal MacKenzie, Judy Oestreicher, Sergei Agoulnik, Michael Byrne, François P. Bernier, Mamoru Yanagimachi, Ken Aoshima, Yoshiya Oda	306
3	P1–234: Circulating miRNA biomarkers for Alzheimer's disease 2013 ·Alzheimer s & Dementia ·Pavan Kumar, Zoltán Dezső, Crystal MacKenzie, Judy Oestreicher, Sergei Agoulnik, (unknown), François P. Bernier, Mamoru Yanagimachi, Ken Aoshima, Yoshiya Oda, Akinori Miyashita, Takeshi Ikeuchi, Ryozo Kuwano	1
4	Abstract 1522: Gene expression profiling (GEP) reveals Epithelial Mesenchymal Transition (EMT) genes selectively differentiating eribulin sensitive breast cancer cell lines. 2013 ·Cancer Research ·Zoltán Dezső, Judith Oestreicher, (unknown), Tadashi Kadowaki, Mamoru Yanagimachi, Junji Matsui, Sergei Agoulnik, Yasuhiro Funahashi	1
5	Abstract 4502: Eribulin alters vascular function in human triple-negative (TN) breast MX-1 and MDA-MB-231 tumor xenograft models as measured by DCE-MRI. 2013 ·Cancer Research ·Paul J. McCracken, Ken Ito, Mamoru Yanagimachi, Xavier Tizon, (unknown), Shanqin Xu, Namita Kumar, (unknown), (unknown), Galina Kuznetsov, Yasuhiro Funahashi	2
6	Abstract A296: Eribulin mesylate suppresses experimental metastasis in the MX-1 human breast cancer model by reversing phenotypic states between epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET). 2013 ·Molecular Cancer Therapeutics ·Taku Yoshida, Galina Kuznetsov, Takayuki Kimura, Naoko Hata Sugi, Hajime Shimizu, Yoichi Ozawa, Yoshiaki Sato, Taisuke Uehara, Hideki Watanabe, Kentaro Takahashi, Kentaro Matsuura, Mai Uesugi, (unknown), Mamoru Yanagimachi, Yasuhiro Funahashi, Junji Matsui	2
7	Squalene synthase inhibitors suppress triglyceride biosynthesis through the farnesol pathway in rat hepatocytes 2003 ·Journal of Lipid Research ·(unknown), Mamoru Yanagimachi, Masashi Ito, Nobuyuki Yasuda, (unknown), (unknown), (unknown), Keigo Tanaka, (unknown), Ichiro Yoshida, Shinya Abe, T. Saeki, Hiroshi Tanaka	38
8	Squalene synthase inhibitors reduce plasma triglyceride through a low-density lipoprotein receptor-independent mechanism 2001 ·European Journal of Pharmacology ·(unknown), Mamoru Yanagimachi, Masashi Ito, T. Saeki, Ichiro Yoshida, (unknown), (unknown), (unknown), Keigo Tanaka, (unknown), Hiroshi Tanaka	27
9	Effect of ER-27856, a novel squalene synthase inhibitor, on plasma cholesterol in rhesus monkeys: comparison with 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors 2000 ·Journal of Lipid Research ·(unknown), Mamoru Yanagimachi, Masashi Ito, (unknown), Ichiro Yoshida, T. Saeki, Hiroshi Tanaka	53
10	Antibody to Thrombin Receptor Inhibits Neointimal Smooth Muscle Cell Accumulation Without Causing Inhibition of Platelet Aggregation or Altering Hemostatic Parameters After Angioplasty in Rat 1998 ·Circulation Research ·Masahiro Takada, Hiroshi Tanaka, (unknown), Osamu Ito, (unknown), Mamoru Yanagimachi, Takanori Kawamura, (unknown), (unknown), Masashi Ito, Hiroko Kobayashi, Shinji Yoshitake, Isao Saito	44
11	Anti-atherosclerotic effect of E5324, an inhibitor of acyl-CoA:cholesterol acyltransferase, in Watanabe heritable hyperlipidemic rabbits 1996 ·Atherosclerosis ·(unknown), Hiroshi Tanaka, (unknown), (unknown), Hiroko Kobayashi, T. Saeki, Masahiro Takada, (unknown), Mamoru Yanagimachi, Teiji Kimura, Shinji Yoshitake, Isao Saito	10
12	Impact of monocyte colony-stimulating factor upon β-very low density lipoprotein (β-VLDL) cholesterol metabolism in tetradecanoyl phorbol acetate-derived THP-1 cells 1994 ·Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·Itsuko Ishii, Mamoru Yanagimachi, Kohji Shirai, (unknown), Seiyu Hirose	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact